Subscribe today for more stories, tips, and updates.

Cincinnati Children's Blog
  • Subscribe
  • CincinnatiChildrens.org
  • Contact Us
  • Blog
  • Healthy Living
  • Rare and Complex Conditions
  • Safety and Prevention
  • Heart Conditions
  • Learning and Growing
  • Research and Discoveries
  • ?
  • Blog
  • Healthy Living
  • Rare and Complex Conditions
  • Safety and Prevention
  • Heart Conditions
  • Learning and Growing
  • Research and Discoveries
  • ?
  • Subscribe
  • CincinnatiChildrens.org
  • Contact Us
HOME/Research and Discoveries/Experimental Treatment Could Deliver Knockout Punch for Newly Diagnosed Neuroblastoma in Kids

Experimental Treatment Could Deliver Knockout Punch for Newly Diagnosed Neuroblastoma in Kids

 

June 12, 2012
0 Comments
By: Cincinnati Children’s News Team

An experimental chemo-radiation treatment is being tested in newly diagnosed cases of high-risk neuroblastoma – a deadly, hard-to-cure childhood cancer.

The experimental radiopharmaceutical, 131I-MIBG, has already shown encouraging results in reducing tumor size in children with relapsed and resistant neuroblastoma.

Dr. Weiss is the medical director of the Neuroblastoma Program at Cincinnati Children's. This has prompted doctors in a multi-center pilot clinical trial being led by Cincinnati Children’s oncologist Brian Weiss, MD, to see if the innovative combination therapy can improve cure rates for newly diagnosed children and young adults.

Unlike some diseases, there is no single detectable biological sign of neuroblastoma, so it’s hard to catch early. Children who relapse usually don’t survive more than a few years. “We want to see if giving this intense treatment right after diagnosis will safely decrease the chances of the cancer coming back,” says Weiss.

Standard treatment for neuroblastoma normally includes several rounds of chemotherapy combined with surgery and external radiation.

In the current trial, a round of chemotherapy will be replaced by an injection of 131I-MIBG combined with the chemotherapy drugs. The chemotherapy drugs will kill some of the cancer cells and, according to research, may help 131I-MIBG do a better job of eradicating tumor cells, without damaging other healthy cells.

WATCH an interview with Dr. Brian Weiss and READ MORE about the study on our website newsroom.

About Neuroblastoma
Neuroblastoma is a rare disease in which a solid tumor (a lump or mass caused by uncontrolled or abnormal cell growth) is formed by special nerve cells called neuroblasts. Normally, these immature cells grow and mature into functioning nerve cells. But in neuroblastoma, they become cancer cells instead.

Neuroblastoma most commonly starts in the tissue of the adrenal glands, the triangular glands on top of the kidneys that produce hormones responsible for controlling heart rate, blood pressure, and other important functions. Like other cancers, neuroblastoma can spread (metastasize) to other parts of the body, such as the lymph nodes, skin, liver, and bones.
Children diagnosed with neuroblastoma are usually younger than 5 years old, with the majority of new cases occurring among those younger than 1 year old.

Subscribe today for more stories, tips, and updates.

Related Articles

Misconceptions about Von Willebrand Disease in Teen Girls
Misconceptions about Von Willebrand Disease in Teen Girls
<strong>MRI’s Role in Your Child’s Proton Therapy</strong> 
MRI’s Role in Your Child’s Proton Therapy 
Would You Pass This Pesticide Safety Quiz?
Would You Pass This Pesticide Safety Quiz?
<strong>Radiology’s Got Heart</strong>
Radiology’s Got Heart
TAGS:
Avatar photo

About the author: Cincinnati Children’s News Team

The members of the news team at Cincinnati Children's are responsible for telling the stories of the medical center. Stories of the families we serve, research and clinical care, safe and healthy practices and happenings at the hospital. If it has to do with Cincinnati Children's, Danielle, Nick, Jim, Kate, Rachel, Terry and Shannon will keep you informed.

Write A Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

No Comments Yet

Topics

  • Cancer and Blood Diseases
  • Child Development and Behavior
  • Childhood Obesity
  • Chronic Care Networks
  • Cincinnati Walks for Kids
  • Featured Faces
  • Fetal Conditions
  • Fitness and Nutrition
  • Food Allergies
  • Ghana 2012
  • Health Care Public Policy
  • Health Care Quality
  • Health Care Reform
  • Healthy Living
  • Heart Conditions
  • Hospital Operations
  • How We Do It
  • Learning and Growing
  • Meet The Team
  • Nurses Week 2012
  • Patient Family Experience
  • Patient Flow
  • Patient Safety
  • Patient Stories
  • Pin of the Week
  • Radiology
  • Rare and Complex Conditions
  • Research
  • Research and Discoveries
  • Safety and Prevention
  • Share Your Story
  • Technology
  • Uncategorized
  • Vaccines
  • Volunteerism
  • What Makes Us Different
  • What's New
See All Topics
See Less Topics

Subscribe

Never miss a post! Sign up to get new blog updates delivered to your email.

Popular Posts

  • 6 Questions to Ask When Your Child Complains of Chest Pain 2.2k views
  • Caring for the Caregivers of Children with Congenital Heart Disease  1.5k views
  • Stuttering In Young Kids: When To Be Concerned 0.9k views
  • 4 Questions to Ask When Your Child Has Recurrent Croup 731 views
  • Laryngomalacia: Is My Child’s Noisy Breathing Serious? 693 views
  • What’s the difference between a CAT-Scan and a CT-Scan? 586 views
About

The Cincinnati Children’s blog features thoughts and perspectives from our experts on all things pediatric health. This blog does not provide medical advice, diagnosis, or treatment. Learn More »

Contact Us
  • 3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
  • 1-513-636-4200 | 1-800-344-2462
  • TTY: 1-513-636-4900
  • socialmedia@cchmc.org
Connect With Us
  • Subscribe
  • CincinnatiChildrens.org
  • Contact Us

© 2009-2022 Cincinnati Children’s Hospital Medical Center